Enanta(美国)

Enanta

Enantawww.enanta.com美国制药公司Enanta公司研发丙肝药物EnantaPharmaceuticalsisaresearchanddevelopment-focusedbiotechnologycompanythatusesitsrobustchemistry-drivenapproachanddrugdiscoverycapabilitiestocreatesmallmole culedrugsintheinfectiousdiseasefield.EnantaisdiscoveringanddevelopingnovelinhibitorsdesignedforuseagainstthehepatitisCvirus(HCV).Theseinhibitorsincludemembersofthedirectactingantiviral(DAA)inhibitorclasses–protease(partneredwithAbbVie),NS5A(partneredwithNovartis)andnucleotidepolymerase–aswellasahost-targetedantiviral(HTA)inhibitorclasstargetedagainstcyclophilin.Additionally,Enantahascreatedanewclassofantibiotics,calledBicyclolides,forthetreatmentofmulti-drugresistantbacteria,withacurrentfocusondevelopinganintravenousandoraltreatmentforhospitalandcommunityMRSA(methicillin-resistantStaphylococcusaureus)infections.